Evogene
EVGN
EVGN
26 hedge funds and large institutions have $1.2M invested in Evogene in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
17% less call options, than puts
Call options by funds: $19K | Put options by funds: $23K
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
26
Holding in Top 10
–
Calls
$19K
Puts
$23K
Top Buyers
| 1 | +$80K | |
| 2 | +$30.4K | |
| 3 | +$13K | |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$11.4K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$6.86K |
Top Sellers
| 1 | -$137K | |
| 2 | -$68K | |
| 3 | -$28.9K | |
| 4 |
SIGI
Susquehanna International Group (Ireland)
Dublin,
Ireland
|
-$21K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$8K |